SCHEMBL3842323

SCHEMBL3842323

CCCCN(C)P(=O)(N(C)CCCC)N(C)CCCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP3 P08254 1/20 0.43
MMP8 P22894 1/20 0.43
S1PR2 O95136 1/20 0.39
S1PR1 P21453 1/20 0.39
S1PR3 Q99500 1/20 0.39
S1PR5 Q9H228 1/20 0.39
DNM1 Q05193 3/20 0.38
GGPS1 O95749 4/20 0.36
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA9 Q16790 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
FDPS P14324 1/20 0.35
AGTR1 P30556 1/20 0.35
OPRM1 P35372 1/20 0.35
PDE3A Q14432 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10946036 0.75 DNM1 (0.43) S1PR2S1PR1S1PR3S1PR5DNM1
SCHEMBL20215376 0.75 FAAH (0.38) MMP1MMP2MMP3MMP8S1PR2
SCHEMBL9246188 0.74 MMP1 (0.44) MMP1MMP2MMP3MMP8S1PR2
Tetramethylammonium Ion SCHEMBL11658185 0.74 MMP1 (0.36) MMP1MMP2MMP3MMP8S1PR2
SCHEMBL13810959 0.72 DNM1 (0.38) MMP1MMP2MMP3MMP8S1PR2
Hexane SCHEMBL11553595 0.71 LPAR3 (0.42) S1PR2S1PR1S1PR3S1PR5DNM1
SCHEMBL409303 0.70 DNM1 (0.48) S1PR2S1PR1S1PR3S1PR5DNM1
SCHEMBL408278 0.70 DNM1 (0.48) S1PR2S1PR1S1PR3S1PR5DNM1
SCHEMBL1566639 0.70 DNM1 (0.48) S1PR2S1PR1S1PR3S1PR5DNM1
Phosphoric Acid SCHEMBL28620622 0.70 DNM1 (0.55) MMP1MMP2MMP3MMP8S1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1876181-B1 IONIC LIQUID CONTAINING PHOSPHONIUM ION AND METHOD FOR PRODUCING SAME KANTO DENKA KOGYO KK (JP) 2013-07-24 EP disclosed
US-20090023954-A1 Ionic liquid containing phosphonium ion and method for producing the same KANTO DENKA KOGYO CO., LTD. (JP) 2009-01-22 US disclosed
US-20090023954-A1 Ionic liquid containing phosphonium ion and method for producing the same KANTO DENKA KOGYO CO., LTD. (JP) 2009-01-22 US disclosed
EP-1876181-A1 IONIC LIQUID CONTAINING PHOSPHONIUM ION AND METHOD FOR PRODUCING SAME Kanto Denka Kogyo CO., LTD. (JP) 2008-01-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023954-A1 Ionic liquid containing phosphonium ion and method for producing the same PHOSPHO1, INPPL1, PIP5K1C MMP1 1625/4885MMP2 4341/4885MMP3 4480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.